Related Experiment Videos
Danazol for uterine fibroids.
Lin-Qiu Ke1, Kun Yang, Jing Li
1West China Medical School of Sichuan University, South of Renmin Road 17#, Chengdu, China.
The Cochrane Database of Systematic Reviews
|July 10, 2009
Summary
No studies were found to evaluate danazol for uterine fibroids. Therefore, there is no reliable evidence on the benefits or harms of using danazol to treat this common gynecological condition.
Area of Science:
- Gynecology
- Reproductive Medicine
- Pharmacology
Background:
- Uterine fibroids are the most common benign tumors in the female reproductive system.
- Danazol, a synthetic derivative of testosterone, has been historically used for uterine fibroid treatment.
Purpose of the Study:
- To assess the effectiveness and safety of danazol in managing uterine fibroids.
- To synthesize evidence from randomized controlled trials on danazol's efficacy.
Main Methods:
- A comprehensive literature search was conducted across multiple databases including Cochrane, MEDLINE, and EMBASE up to December 2008.
- Inclusion criteria focused on randomized controlled trials comparing danazol to placebo or other medical therapies for uterine fibroids.
Main Results:
- No studies met the inclusion criteria for this review.
- Consequently, no data on the effectiveness or safety of danazol for uterine fibroids could be extracted or analyzed.
Conclusions:
- There is a lack of reliable evidence from randomized controlled trials to support or refute the use of danazol for treating uterine fibroids.
- Further research in the form of well-designed clinical trials is needed to establish danazol's role in managing uterine fibroids.
Related Concept Videos
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
01:16Uterine Tubes
The uterine or fallopian tubes function as the conduit through which oocytes travel from the ovaries to the uterus. Each fallopian tube measures approximately 10 to 13 cm long and is anatomically divided into the infundibulum, ampulla, isthmus, and interstitial part (or intramural segment). The infundibulum is characterized by its funnel shape and features extensions called fimbriae which reach towards the peritoneal cavity. These fimbriae play a critical role during ovulation as they extend...
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.